Ownership history in ALGERT GLOBAL LLC · 15 quarters on record
This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in FATE THERAPEUTICS INC (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 106,920 | +41,410 | +63.2% | 0.00% | $135K | $1.26 |
| 2024 Q4 | REDUCED | 65,510 | -101 | -0.2% | 0.00% | $108K | $1.65 |
| 2024 Q3 | UNCHANGED | 65,611 | — | 0% | 0.01% | $230K | $3.50 |
| 2024 Q2 | ADDED | 65,611 | +49,931 | +318.4% | 0.01% | $215K | $3.28 |
| 2024 Q1 | REDUCED | 15,680 | -64,974 | -80.6% | 0.00% | $115K | $7.34 |
| 2023 Q4 | REDUCED | 80,654 | -11,210 | -12.2% | 0.01% | $302K | $3.74 |
| 2023 Q3 | REDUCED | 91,864 | -444,967 | -82.9% | 0.01% | $195K | $2.12 |
| 2023 Q2 | ADDED | 536,831 | +156,294 | +41.1% | 0.11% | $2.6M | $4.76 |
| 2023 Q1 | ADDED | 380,537 | +359,181 | +1681.9% | 0.10% | $2.2M | $5.70 |
| 2022 Q1 | ADDED | 21,356 | +12,245 | +134.4% | 0.05% | $828K | $38.77 |
As of 2025 Q4 — sorted by position size